Product Overview

Canertinib is a highly selective small-molecule tyrosine kinase inhibitor primarily used in the development of anti-tumor drugs, particularly in the targeted therapy of EGFR-mutant lung cancer and other related malignancies. This product is suitable for early-stage drug development, including laboratory trials, pilot-scale production, and commercial manufacturing. It is widely used in innovative drug development, generic drug process optimization, and customized synthesis projects, and is a crucial raw material for pharmaceutical companies and research institutions in the field of cancer treatment.

Applications

• Synthesis of antitumor drug intermediates
• Development of EGFR target inhibitors
• Optimization of drug manufacturing processes
• Preparation of standards for preclinical studies
• Industrialization development of innovative and generic drugs

Quality & Supply Capability

English Name: Canertinib Properties: White to off-white crystalline powder, readily soluble in organic solvents, with good thermal stability. Its structure contains phenyl and piperazine groups, exhibiting well-defined chemical characteristics. Storage Recommendations: Store in a sealed, light-protected, and dry place, referring to the COA/MSDS for specific details. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches. Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging. Document Support: COA, MSDS, HPLC, NMR, etc. We provide a full-process service from sample supply to small-scale preparation, pilot-scale amplification, and customized mass production. We can flexibly adjust the supply plan according to the customer's specific requirements for purity, impurity control, packaging specifications, delivery cycle, and quality documentation. Simultaneously, we have a professional technical support team to assist customers in completing the entire process from laboratory R&D to industrial scale-up, including process development, route optimization, and project transformation, ensuring efficient, stable, and compliant fulfillment of customer needs.

Why Choose Bioncan

Focused on oncology drug intermediates and APIs, possessing extensive industry experience. Full-scale supply capabilities, covering all stages from laboratory to commercial production. Provides complete quality control documentation, complying with international drug registration and quality control standards. Supports customized solutions, flexibly responding to the technical and market requirements of different clients. Offers comprehensive process optimization and scale-up technical support, helping clients achieve technology transfer and product commercialization.

Intermediates of Canertinib

Online Consulting

For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 267243-28-7, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.